In this Issue:
Vosaroxin + cytarabine in first relapsed/refractory AML
Add-on sorafenib in younger patients with newly diagnosed AML
AG-221 for IDH2-positive advanced haematological malignancies
ABT-199 in AML
CSL362 in CD123+ AML in CR at high risk for early relapse
Allogeneic SCT in CMML
Methotrexate dose alterations in allogeneic SCT
Azacitidine in elderly AML with myelodysplasia-related changes
Eculizumab during pregnancy in PNH
Please login below to download this issue (PDF)